Daxor Corporation (DXR)

NASDAQ

$10.14

$--

(0.00%)

Pre-Market

Daxor Corporation (DXR) Live Price Chart

Last updated: ⁦2026-10-13 13:19:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Daxor Corporation (DXR) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $10.14, with a market capitalisation of $60.78M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $8.56 to $14.76. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$60.78M
Open	$10.14
Day's High	$24.60
Day's Low	$3.40
Previous Close	$10.30
Volume	2.00
Average Volume	17.86K
P/E Ratio	--
52-Week High	$14.76
52-Week Low	$8.56
Dividend Yield	--
Earnings Date	--

Daxor Corporation (DXR) Pre-Market Stock Price

Daxor Corporation (DXR) is trading at $10.14 in pre-market trading as of 2026-10-13 11:42:00, down 1.64% ($0.17) from the previous close of $10.30

Pre-market trading shows how investors are pricing DXR before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

Daxor Corporation (DXR) 7-Day Stock Price Change

Over the past seven days, Daxor Corporation (DXR) moved from $10.62 to $10.14, representing a decline of 4.57% ($0.48).

The stock traded between $10.02 and $11.07 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.

The average daily volume was 9.21 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

DXR 52-Week Price Position

Position in Range: 25.4%

52W Low$8.56

52W High$14.76

DXR is currently trading at $10.14, placing it 25.4% of the way from its 52-week low of $8.56 to its 52-week high of $14.76. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Daxor Corporation (DXR)?

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system. The company operates as a single business segment centered on the development, commercialization, and support of its proprietary blood volume analysis technology used by healthcare providers.

Daxor Corporation Information

Industry	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees	750
Exchange	NASDAQ
Company Website	https://www.daxor.com

How to Buy Daxor Corporation (DXR) Stock on MEXC

Eligible investors can buy real shares of Daxor Corporation (DXR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for DXR and Place Your Order

Open the RealStocks trading page and search for DXR. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Daxor Corporation (DXR) stock price today?

Daxor Corporation (DXR) is currently trading at $ 10.14, down 1.64% ($0.17) from the previous close of $ 10.30. Intraday prices update in real time during regular trading hours.

2.Is DXR stock going up or down today?

As of 2026-10-13 11:42:00, DXR is trading at $ 10.14, down 1.64% ($0.17) from its previous close of $ 10.30. The stock has traded between $ 3.40 and $ 24.60 during today’s regular session. Past price movements do not guarantee future results.

3.What is DXR pre-market price?

As of 2026-10-13 11:42:00, DXR is trading at $ 10.14 in pre-market trading, down 1.64% ($0.17) from the previous close of $ 10.30. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is DXR after-hours price?

As of 2026-10-13 11:42:00, DXR is trading at $ 10.14 in after-hours trading, down 1.64% ($0.17) from the regular-session close of $ 10.30. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is DXR stock trading now?

DXR trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does DXR sit relative to its 52-week high and low?

Over the past 52 weeks, DXR has traded between a low of $ 8.56 and a high of $ 14.76. At $ 10.14, the stock is positioned 25.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Daxor Corporation in?

Daxor Corporation (DXR) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Daxor Corporation's market capitalisation and where is it listed?

Daxor Corporation is listed on the NASDAQ exchange with a market capitalisation of $ 60.78M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is DXR valued in terms of P/E ratio and EPS?

DXR trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Daxor Corporation pay a dividend?

Daxor Corporation pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.